Addiction Disorders

2005;80(1):105–16. 6. 7. 8.

Hughes JR, Peters EN, Callas PW, et al., Attempts to stop or reduce marijuana use in non-treatment seekers, Drug

Alcohol Depend, 2008;97(1–2):180–84.

Nordstrom BR, Levin FR, Treatment of cannabis use disorders: a review of the literature, Am J Addict, 2007;16(5):331–42.

Budney AJ, Higgins ST, Radonovich KJ, Novy PL, Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for

marijuana dependence, J Consult Clin Psychol, 2000;68(6):

1051–61.

9.

Dennis M, Godley SH, Diamond G, et al., The Cannabis Youth Treatment (CYT) Study: main findings from two

randomized trials. J Subst Abuse Treat, 2004;27(3):197–213.

10. Marijuana Treatment Project Research Group, Brief treatments for cannabis dependence: findings from a

randomized multisite trial, J Consult Clin Psychol,

2004;72(3):455–66.

11. Levin FR, McDowell D, Evans SM, et al., Pharmacotherapy for marijuana dependence: a double-blind, placebo- controlled pilot study of divalproex sodium, Am J Addict, 2004;13(1):21–32.

12. Carpenter KM, McDowell D, Brooks DJ, et al., A preliminary trial: double-blind comparison of nefazodone, bupropion- SR, and placebo in the treatment of cannabis dependence,

Am J Addict, 2009;18(1):53–64.

13. Ben Amar M, Cannabinoids in medicine: a review of their therapeutic potential, J Ethnopharmacol, 2006;105(1–2):1–25.

14. Devane WA, Dysarz FA, 3rd, Johnson MR, et al., Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol, 1988;34(5):605–13.

15. Munro S, Thomas KL, Abu-Shaar M, Molecular characterization of a peripheral receptor for cannabinoids, Nature, 1993;365(6441):61–5.

16. Shen M, Thayer SA, Delta-9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture,

Mol Pharmacol, 1999;55(1):8–13.

17. Bossong MG, van Berckel BN, Boellaard R, et al., Delta-9- tetrahydrocannabinol induces dopamine release in the human striatum, Neuropsychopharmacology, 2009;34:759–66.

18. Zhang PW, Ishiguro H, Ohtsuki T, et al., Human cannabinoid receptor 1: 5’ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse, Mol Psychiatry, 2004;9(10):916–31.

19. Haughey HM, Marshall E, Schacht JP, et al., Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes, Addiction, 2008;103(10):1678–86.

20. Egertova M, Giang DK, Cravatt BF, Elphick MR, A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain, Proc Biol Sci, 1998;265(1410):2081–5.

21. Sipe JC, Chiang K, Gerber AL, et al., A missense mutation in human fatty acid amide hydrolase associated with problem

drug use, Proc Natl Acad Sci U S A, 2002;99(12):8394–9.

22. Herman AI, Kranzler HR, Cubells JF, et al., Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence, Am J Med Genet

B Neuropsychiatr Genet, 2006;141B(5):499–503.

23. Clapper JR, Mangieri RA, Piomelli D, The endocannabinoid system as a target for the treatment of cannabis dependence, Neuropharmacology, 2009;56(Suppl. 1):235–43.

24. Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW, Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans,

Psychopharmacology (Berl), 2002;164(4):407–15.

25. Haney M, Gunderson EW, Rabkin J, et al., Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric

intake, mood, and sleep. J Acquir Immune Defic Syndr,

2007;45(5):545–54.

26. Haney M, Rabkin J, Gunderson E, Foltin RW, Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood, Psychopharmacology (Berl), 2005;181(1);170–78.

27. Justinova Z, Tanda G, Redhi GH, Goldberg SR, Self- administration of delta-9-tetrahydrocannabinol (THC) by

drug naive squirrel monkeys, Psychopharmacology (Berl), 2003;169(2):135–40.

28. Hart CL, Haney M, Vosburg SK, et al., Reinforcing effects of oral Delta-9-THC in male marijuana smokers in a laboratory choice procedure, Psychopharmacology (Berl), 2005,181(2): 237–243.

29. Budney AJ, Hughes JR, Moore BA, Vandrey R, Review of the validity and significance of cannabis withdrawal syndrome,

Am J Psychiatry, 2004;161(11):1967–77.

30. Budney AJ, Hughes JR, Moore BA, Novy PL, Marijuana abstinence effects in marijuana smokers maintained in their home environment, Arch Gen Psychiatry, 2001;58(10):917–24.

31. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW, Abstinence symptoms following oral THC administration to humans, Psychopharmacology (Berl), 1999;141(4):385–94.

32. Budney AJ, Novy PL, Hughes JR, Marijuana withdrawal among adults seeking treatment for marijuana dependence, Addiction, 1999;94(9):1311–1322.

33. Haney M, Hart CL, Vosburg SK, et al., Marijuana withdrawal in humans: effects of oral THC or divalproex, Neuropsychopharmacology, 2004;29(1):158–70.

34. Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B, Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms, Drug Alcohol Depend, 2007;86(1):22–9.

35. Levin FR, Kleber HD, Use of dronabinol for cannabis dependence: two case reports and review, Am J Addict, 2008;17(2):161–4.

36. Hart CL, Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies, Drug

Alcohol Depend, 2005;80(2):147–59.

37. Haney M, Hart CL, Vosburg SK, et al., Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse, Psychopharmacology (Berl), 2008;197(1):157–68.

38. Anton RF, O’Malley SS, Ciraulo DA, et al., Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial, JAMA, 2006;295(17):2003–17.

38

US PSYCHIATRY Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68